ASTCT Pharmacy SIG Journal Club - September 2025

The ASTCT Pharmacy SIG September 2025 Journal Club will air on Wednesday, September 24 at 2 p.m. CT/3 p.m. ET. This webinar consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q & A session. In the September Journal Club session, Drs. Yi and Trinh will present two articles related to:

• Enhanced CAR T-cell therapy for lymphoma after previous failure
• Linvoseltamab for the treatment of relapsed/refractory multiple myeloma 

Presenters & Articles:

Ha Nguyen Trinh, PharmD

PGY-2 Pharmacy Resident

Emory Healthcare | Winship Cancer Institute 

Article: Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure

Hannah Yi, PharmD

PGY-2 Pharmacy Resident

UT Southwestern Medical Center

Article: Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

Session Learning Objectives:

Upon completion of the activity, participants should be able to:

• Review the four commercially available anti-CD19 CAR T-cell products and their place in current guideline of CD19+ B-cell lymphomas
• Evaluate the safety and efficacy of the enhanced CART T-cell therapy (huCART19-IL18) in phase 1 trial
• Discuss the clinical implications of huCART19-IL18 for relapsed CD19+ B-cell lymphomas after prior anti-CD19 CAR T-cell therapy
• Describe the current treatment landscape of relapsed/refractory multiple myeloma (RRMM)
• Analyze the efficacy outcomes and safety profile of linvoseltamab in the LINKER-MM1 trial
• Evaluate the potential clinical impact of linvoseltamab in the treatment of RRMM

ACCREDITED PROVIDER

This activity is jointly provided by The France Foundation and American Society for Transplantation and Cellular Therapy (ASTCT).

In support of improving patient care, this activity has been planned and implemented by The France Foundation and American Society for Transplantation and Cellular Therapy (ASTCT). The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION

Pharmacists

This knowledge-based activity qualifies for 1.0 contact hour (0.10 CEU) of continuing pharmacy education credit. Please submit all evaluations and credit requests no later than 30 days after you complete this activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).

All other healthcare professionals completing this course will be issued a statement of participation.

The full accreditation information will be available soon.